
Another grocery run, but for medical supplies
Cardinal Health is back in deal mode. The company said it will buy AdaptHealth’s Diabetes Health business and Strive Medical for a combined $360 million. Not exactly pocket change — but in healthcare land, this is how companies quietly redraw the map.
Why you should care
This looks like Cardinal doubling down on specialty care and patient supply services, the kind of boring-but-profitable stuff that can help smooth out the choppier parts of its business. If the integration goes well, CAH gets a bigger footprint in diabetes and urology-related supplies, two categories with steady demand and long customer relationships.
For AdaptHealth, the move is the opposite: trim the edges, raise cash, and focus on the parts of the business that matter most. Sometimes the best strategy is less “grow at all costs” and more “cut the side quests.”
The investor takeaway
The deal matters because it could:
- Expand CAH’s specialty healthcare reach
- Add a recurring-revenue-ish stream tied to chronic care supply needs
- Help AHCO simplify its portfolio and potentially shore up the balance sheet
Big picture: Cardinal is acting like a company that wants more scale in the unglamorous corners of healthcare — and those corners can be very profitable indeed.
